WHO-GMP certified sourcing
We work only with facilities holding current WHO Good Manufacturing Practice certification, re-verified before each supply cycle.
The medicines that keep you level,
wherever you are.
Levela Health coordinates lawful Named Patient access to diabetes medicines, weight-management therapies, and continuous glucose monitoring — verifying the manufacturer, the batch, and the cold chain before anything leaves the facility.
Start a request
Browse medicines & Devices
75+
Countries served
10+
Certified manufactureres
2–8°C
Monitored cold chain
100%
Pharmacist reviewed
Certificates available on request
Reviewer credentials published
Shipment tracking facility
Import-permit guidance included
Three categories. One verification standard.
A tablet, an injection pen, and a wearable sensor have almost nothing in common clinically — but they pass through exactly the same checks here before a quote is issued.
01 — DIABETES
Diabetes medicines
Oral agents and insulin analogues used across type 1 and type 2 management, in the forms your prescription specifies.
– Biguanides & sulfonylureas
– SGLT2 inhibitors
– DPP-4 inhibitors
– Basal, bolus & premix insulin analogues
Typically requested by patients whose prescribed brand is unregistered, out of stock, or unaffordable in their country.
02 — WEIGHT MANAGEMENT
Weight-management therapies
GLP-1 and dual-agonist injectables dispensed strictly as part of a physician-supervised treatment plan, never as a standalone product.
– Semaglutide (weekly)
– Liraglutide (daily)
– Tirzepatide (weekly)
– Titration-matched pack sizes
Requires an active prescription and a named prescribing physician we can contact for clarification.
03 — MONITORING
Glucose monitoring devices
Continuous glucose monitors, readers, and replacement sensor packs — the hardware that makes everything above measurable.
– 14-day wearable sensors
– Companion readers & transmitters
– Multi-sensor supply packs
– Adhesive overpatches & accessories
Prescription rules for monitoring hardware vary by country — we confirm yours before quoting.
What "Named Patient" access actually means
Most people arrive here having been told a medicine “isn’t available” in their country. That is usually a registration question, not a supply one — and there is a lawful route through it.
A Named Patient Program is a regulatory provision that lets a physician obtain a medicine for one identified patient, by name, when that medicine is approved and marketed elsewhere but is not registered — or not obtainable — in the patient’s own country.
IN PLAIN TERMS
The prescription is written for you specifically. The import is authorised for you specifically. Nothing is stocked, resold, or dispensed to anyone else.
It exists because drug registration is national while illness is not. A therapy can be routinely prescribed in one market and entirely absent from the next, purely for commercial or timing reasons. Regulators in most jurisdictions accept this and provide a documented exception — with conditions attached.
Those conditions are the reason this process has more steps than ordinary online shopping, and the reason we will decline a request we cannot document properly.
i. A named patient with a valid prescription from a licensed physician.
ii. A named prescribing physician who takes clinical responsibility for the treatment.
iii. Quantities consistent with personal treatment — not commercial resale.
iv. Compliance with the destination country’s import rules, which sometimes require an import permit before dispatch.
Requirements differ by jurisdiction. Nothing here is legal advice — confirm your country’s rules with your physician or local regulator, and we will confirm what we can from our side before quoting.
Five checks between the factory and your door
Sourcing generics well is not about finding the cheapest supplier. It is about knowing exactly which facility made a specific batch, and being able to prove it afterwards.
STEP 01
Facility qualification
Each manufacturer’s WHO-GMP status is verified as current before any product from that facility is listed.
STEP 02
Batch & certificate
Batch number, manufacture and expiry dates recorded, with the certificate of analysis matched to that batch.
CoA available on request
STEP 03
Clinical review
Prescription validity, dose plausibility, and interaction flags checked by a licensed pharmacist.
Reviewer named on file
STEP 04
Regulatory clearance
Destination import rules confirmed and export documentation prepared before the order is packed.
STEP 05
Monitored dispatch
Cold-chain packing with a temperature logger where required, plain outer packaging, tracked courier.
Why we sale sensor alongside the medicine
Time in range is the number the medicine is trying to move
An HbA1c reading averages roughly three months into a single figure. It cannot distinguish a steady day from a day that swung between a hypo at dawn and a spike after dinner — two very different clinical pictures with the same average.
Continuous monitoring reports the proportion of the day spent inside the target band instead. That is what makes a titration decision evidence-based rather than a guess, which is why we treat monitoring hardware as part of the same conversation as the prescription — not as an accessory.
>70%
Time in range 70–180 mg/dL
>4%
Time below 70 mg/dL
<25%
Time above 180 mg/dL
Who check what is published here
Before you ask us
Do I need a prescription?
Yes, for every medicine listed. A Named Patient supply exists precisely because a physician has taken responsibility for prescribing it to you. Monitoring devices are treated differently in many countries — we confirm your destination’s rules before quoting.
Why isn't there a price on the product page?
Because an honest figure depends on your country’s import route, the shipping method the product requires, and current batch availability. Publishing a number we would then revise is worse than publishing none. You receive a written quote after review, before any payment is requested.
Are these the same as originator brand?
They are generic or biosimilar products from WHO-GMP certified facilities, containing the same active ingredient at the stated strength. Where a specific bioequivalence study is available for a product, we cite it on that product’s page. Where one is not, we say so plainly rather than implying equivalence we cannot evidence.
What happens if a cold chain shipment is delayed?
The temperature logger travelling with the parcel records the full journey. If it shows an excursion outside the validated range, contact us before using the product and we will review the logger data with you and the manufacturer’s stability information.
Regulatory & Safety Disclosure
What ANewMet Health is
A facilitation service that coordinates lawful Named Patient supply between certified manufacturers and patients holding a valid prescription. We are not a licensed retail pharmacy and we do not practise medicine
What this site is not
Nothing published here is medical advice, a diagnosis, or a substitute for your treating physician. Do not start, stop, or change a dose based on anything you read on this site.
On approval status
WHO-GMP certification describes the manufacturing facility, not a regulatory approval of the product in your country. Approval status varies by jurisdiction and is stated per product where known.
Tell us the medicine and the country. We'll tell you if it's possible.
Most enquiries are answered with a straight yes, no, or “here’s what your regulator will need first” — usually within one working day.
Contact the teamAsk about documentaion